| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP &President Cardiovascular | EVP &Pres Diabetes/ Cardiovasc | EVP &Group President Diabetes
1 company
Salmon Sean is an EVP &President Cardiovascular at Medtronic plc. Recent SEC Form 4 filings include 0 buys and 6 sells.
Estimated insider holdings value: $5.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 21, 2024 | MDT Medtronic Plc | EVP &President Cardiovascular | Sale+OE | 30,695 | $85.13 | $2,613,054.74 | -13.9% | -0.8% | +2.4% | |
| Dec 13, 2022 | MDT Medtronic Plc | EVP &President Cardiovascular | Sale+OE | 16,631 | $80.50 | $1,338,735.63 | -31.5% | -2.7% | +2.2% | |
| Aug 25, 2021 | MDT Medtronic Plc | EVP &Pres Diabetes/ Cardiovasc | Sale+OE | 28,419 | $134.08 | $3,810,492.42 | -29.9% | -15.3% | -29.8% |